How Quickly Must Stroke Treatment Begin to Prevent Permanent Brain Damage?

During an ischaemic stroke, neurons die rapidly with every minute that blood flow is interrupted. The brain has no pain receptors to signal this destruction, so the only indicator of accumulating damage is time itself. Every delay between symptom onset and treatment at home, in transit, or in the emergency department directly translates into neurons lost and function that may never return.

According to Dr. Guruprasad Hosurkar, a leading Neurologist in Bangalore, “The treatment window for stroke is not a rough guideline. It is a biological deadline. A patient who arrives at 4 hours and 20 minutes can receive thrombolysis. A patient who arrives at 4 hours and 40 minutes cannot. That 20-minute difference is often the difference between walking out of hospital independently and needing lifelong care. The delay almost never happens in the hospital. It happens at home, while the family waits to see if things improve.”

Stroke treatment is defined by time-based windows, and arrival at hospital is the single most modifiable factor in outcomes.

• Thrombolysis window 4.5 hours: tPA dissolves the clot in ischaemic stroke, but benefit disappears and bleeding risk rises sharply after 4.5 hours. Recognising the first warning signs of a Brain Stroke and acting immediately is what keeps patients within this window.
• Mechanical thrombectomy up to 24 hours: For large vessel occlusion where perfusion imaging confirms salvageable tissue, endovascular clot retrieval remains beneficial up to 24 hours, provided the ischaemic core is small relative to the penumbra.
• Door-to-needle target under 60 minutes: Every 15-minute improvement in time from hospital arrival to thrombolysis produces measurable improvement in functional outcomes at 90 days.
• Wake-up stroke requires MRI guidance: When onset is unknown because the patient woke with deficits, perfusion MRI identifies whether tissue is still salvageable and guides thrombolysis decisions.

Each of these windows closes permanently once passed. Time is brain is not a slogan it is a precise clinical statement grounded in the fact that approximately 1.9 million neurons are lost every minute a stroke goes untreated.

Arriving early is necessary but not sufficient. What happens between arrival and treatment initiation is equally important.

• Non-contrast CT rules out haemorrhage first: tPA cannot be given without imaging because haemorrhagic stroke, around 15% of all strokes, is an absolute contraindication to thrombolysis and requires completely different management.
• Blood glucose, BP, and coagulation checks run in parallel with imaging: Hypoglycaemia mimics stroke, uncontrolled hypertension affects thrombolysis safety thresholds, and anticoagulant use changes the treatment decision these assessments run simultaneously, not sequentially.
• CT angiography identifying large vessel occlusion triggers the thrombectomy pathway directly: If a proximal artery occlusion is confirmed, the patient moves to the angiography suite without waiting to assess thrombolysis response, as combined therapy produces better outcomes than either alone.
• Stroke unit admission follows acute treatment: The 72 hours after stroke carry the highest risk of deterioration, recurrence, and complications including aspiration pneumonia and DVT. Stroke unit care reduces 30-day mortality by approximately 20% compared to general ward management.

The hospital cannot make up for time lost before arrival, but a well-functioning stroke pathway ensures every remaining minute is used as efficiently as possible which is why understanding what the first warning signs of a brain stroke look like and acting on them immediately remains the single most important factor in determining how much of that window is still open when the patient arrives.

Dr. Guruprasad Hosurkar practises at KIMS Hospital, Mahadevapura, with specialist expertise in acute stroke management, TIA evaluation, and long-term secondary prevention. For patients who have experienced a stroke or TIA and want a structured neurological review of their risk profile and ongoing management, early specialist input is where the most meaningful reduction in recurrence risk is achieved.